• Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Research and innovation
    • Quality and certifications
    • Commitment to sport
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • Cetilar Crema
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
  • Investor Relations
    • INVESTOR
      • Shares study and research
      • Share capital and Shareholders
      • Financial statements
      • SDIR
      • Corporate events
      • Company presentation
      • Notice of meetings
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • Media
    • News
    • Social commitment
  • Careers
    • Work with us
    • Job offers
  • Group
    • Companies
    • History
    • Business model
    • Mission and vision
    • Corporate values
    • Research and innovation
    • Quality and certifications
    • Commitment to sport
  • Brands
    • PharmaNutra
      • SiderAL
      • SiderAL Forte
      • SiderAL Folico
      • Cardio SiderAL
      • Cetilar Crema
      • ApportAL
      • UltraMag
      • Gestalys DHA
      • Novomega
      • Bonecal
      • DiKappa2
    • Junia Pharma
    • Alesco
  • Investor Relations
    • INVESTOR
      • Shares study and research
      • Share capital and Shareholders
      • Financial statements
      • SDIR
      • Corporate events
      • Company presentation
      • Notice of meetings
      • AIM admission document
      • MTA prospectus
    • PRESS
      • Press releases
      • Press review
  • Governance
    • Board of Directors and Committees
    • Company documents
    • Internal dealing
    • Statutory auditors and Audit firm
    • Sharholders Agreements
  • Media
    • News
    • Social commitment
  • Careers
    • Work with us
    • Job offers
  • it
  • en

Internal dealing

  • INTERNAL DEALING 23/09/2020 BEDA SRL – CARLO VOLPI
  • INTERNAL DEALING 23/09/2020 ROBERTO LACORTE
  • INTERNAL DEALING 23/09/2020 ANDREA LACORTE
  • INTERNAL DEALING 16/04/2019 ROBERTO LACORTE
  • INTERNAL DEALING 16/04/2019 ANDREA LACORTE
  • INTERNAL DEALING 16/04/2019 GIANNI LAZZARINI
  • INTERNAL DEALING 16/04/2019 BEDA SRL CARLO VOLPI
  • INTERNAL DEALING 08/10/2018 ROBERTO LACORTE
  • INTERNAL DEALING 09/10/2018 ANDREA LACORTE
  • INTERNAL DEALING BEDA SRL CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING LAZZARINI GIANNI CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING TARANTINO GERMANO CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING LACORTE ROBERTO CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING LACORTE ANDREA CONVERSIONE PAS 19/10/2017
  • INTERNAL DEALING 07/12/2017 BEDA SRL
  • INTERNAL DEALING 07/12/2017 LAZZARINI GIANNI
  • INTERNAL DEALING 07/12/2017 TARANTINO GERMANO
  • INTERNAL DEALING 07/12/2017 LACORTE ROBERTO
  • INTERNAL DEALING 07/12/2017 LACORTE ANDREA

PharmaNutra Spa

Registered office

Via Delle Lenze, 216/b - 56122 Pisa

Phone +39 050 7846500

Fax +39 050 7846524

Electronic billing code

SUBM70N

C.F. / P.Iva / Reg. Impr. 01679440501

Share capital € 1.123.097,70

I.V. | REA 146259

Contacts

Info
info@pharmanutra.it
Candidature
recruiting@pharmanutra.it
Commerciale
commerciale@pharmanutra.it
Investor relations
investorrelation@pharmanutra.it
Distribution
internationaldept@pharmanutra.it

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.
Read Newsletter Disclosure

Subscribe to the newsletter
Privacy policy Cookie policy General conditions Code of ethics 231 Model

© 2020 PharmaNutra SpA - All rights reserved